🚨New publication in Brain Communications!
In this study, we show that microglial cells play a key role in Alzheimer's disease, particularly in regulating changes in soluble tau, based on cell-type-specific genetic evidence.
🔗Full paper: https://t.co/nZzf1r33vz
Good morning! After a great first day of #AAIC2025 with an amazing welcoming reception, we hope to see you bright and early on the second day at our talks and posters!
New study compares plasma p-Tau assays in postmortem-confirmed #Alzheimer’s disease. ALZpath p-Tau217 performs like p-Tau181, but Lilly’s p-Tau217 shows stronger links to pathology & higher accuracy #AEScienceWatch
https://t.co/5CoLZye3Tt
As FDA-approved Alzheimer’s treatments reach patients, validating the ALZpath p-Tau217 assay against gold standard neuropathological outcomes is key. Our new neuropathology cohort study led by @DivyaBali06 is now out in Acta Neuropathologica Comms! 🔗https://t.co/46GpHNfx5v